Gavin Baker’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588M Sell
1,216,795
-2,148,992
-64% -$570M 4.1% 6
2026
Q1
$369M Buy
3,365,787
+1,754,593
+109% +$250M 7.37% 2
2025
Q4
$268M Buy
1,611,194
+1,549,144
+2,497% +$259M 3.28% 7
2025
Q3
$12.1M Sell
62,050
-892,733
-94% -$147M 0.24% 53
2025
Q2
$86.3M Sell
954,783
-3,697,481
-79% -$292M 2.4% 18
2025
Q1
$278M Buy
4,652,264
+2,815,614
+153% +$260M 8.43% 1
2024
Q4
$243M Sell
1,836,650
-5,331,840
-74% -$500M 5.33% 2
2024
Q3
$376M Buy
7,168,490
+4,392,161
+158% +$206M 9.56% 2
2024
Q2
$168M Buy
2,776,329
+110,537
+4% +$7.67M 5.49% 4
2024
Q1
$198M Buy
+2,665,792
New +$198M 4.49% 5

Other funds holding ALAB

Gavin Baker's ALAB Position: Q2 2026 in Review

Gavin Baker reduced its Astera Labs (ALAB) stake by 64% in Q2 2026, selling an estimated $570M and leaving 1,216,795 shares worth $588M. The position accounts for 4.1% of the portfolio, ranked #6.

Gavin Baker first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 984 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Gavin Baker held 1,216,795 shares of Astera Labs worth $588M as of Q2 2026.
  • Gavin Baker sold 2,148,992 Astera Labs shares in Q2 2026, an estimated $570M.
  • Astera Labs made up 4.1% of Gavin Baker's portfolio in Q2 2026, its #6 holding.
  • Gavin Baker first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 984 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Atreides Management's 13F filing for Q2 2026, filed 14 Aug 2026.